Abstract
This article will review the background for concerns regarding consistency in labeling for products marketed in several countries, the pharmaceutical industry's response to those concerns, and will briefly describe a recent Congressional request to the Office of Technology Assessment for a comprehensive study of this subject. Finally, a description will be given of methods used by several multinational companies in achieving labeling consistency on a worldwide basis.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
